Akanocure Pharmaceuticals, Inc.

Akanocure Pharmaceuticals, Inc. is a drug development company that utilizes an innovative chemistry platform to design and synthesize novel small molecules. Founded in 2015 and based in West Lafayette, Indiana, the company integrates chemical methodology development with drug discovery expertise to create compounds for orphan and unmet medical needs. Their technology focuses on enabling the efficient discovery, optimization, and large-scale manufacturing of complex oral drug-like compounds, including those designed to target undruggable protein-protein interactions.

The company is actively engaged in oncology research, specifically seeking to block metastatic processes, which are responsible for the majority of cancer-related deaths. Beyond oncology, Akanocure leverages its platform to develop broad-spectrum antiviral agents, including host-directed therapies designed to address both current and future viral threats. Furthermore, the company has expanded its application into the agricultural sector, where it develops novel antifungal agents for crop protection. These initiatives are supported by competitive research grants from organizations such as the National Science Foundation and industry partnerships with global firms like Bayer.